Annual diabetes cost estimates for 2007

Jan 22 2008

The American Diabetes Association (ADA), members of the Congressional Diabetes Caucus and diabetes experts, will host a congressional briefing, Wednesday, January 23 at 1 p.m. in 2218 Rayburn House Office Building to discuss the annual diabetes cost estimates for 2007, which were compiled in a study by the Lewin Group on behalf of the ADA.

During this briefing, speakers will release staggering new figures about the direct and indirect costs of the disease, and reveal the devastating expense incurred by Americans.

Invited speakers include leaders from the Congressional Diabetes Caucus: Representatives Diana DeGette (D-CO), Mike Castle (R-DE), Xavier Becerra (D-CA) and Mark Kirk (R-IL); Stewart Perry, Chairman of the Board, ADA; Ann L. Albright, PhD, RD, President, Health Care & Education, ADA; Griffin Rodgers, MD, MACP, Director, National Institutes of Diabetes and Digestive Kidney Diseases, National Institutes of Health, and Ed Gregg, PhD, Chief, Epidemiology and Statistics Branch, Division of Diabetes Translation, Centers for Disease Control and Prevention.

Diabetes is the fifth leading cause of death by disease in the United States. Since 1987, the death rate due to diabetes has increased by 45 percent, while the death rates due to heart disease, stroke, and cancer have declined.

What: The American Diabetes Association, along with Members of the Congressional Diabetes Caucus and diabetes experts will hold a briefing on new diabetes cost estimates and the economic impact of the disease.

When: Wednesday, January 23 at 1 p.m.

Where: 2218 Rayburn House Office Building

Who: Invited speakers include leaders from the Congressional Diabetes Caucus, Representatives Diana DeGette (D-CO), Mike Castle (R-DE), Xavier Becerra (D-CA) and Mark Kirk (R-IL); Stewart Perry, Chairman of the Board, ADA; Ann L. Albright, PhD, RD, President, Health Care and Education, ADA; Griffin Rodgers, MD, MACP, Director, National Institutes of Diabetes and Digestive Kidney Diseases, National Institutes of Health, and Ed Gregg, PhD, Chief,
Epidemiology and Statistics Branch, Division of Diabetes Translation, Centers for Disease Control and Prevention.